| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| February 19, 2010 | Chief Executive Offier | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 85,000 | $2.94 | 698,334 | |
| February 19, 2010 | Interim CAO, Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,040 | $2.94 | 2,040 | |
| February 19, 2010 | Interim CAO, Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | $2.94 | 15,000 | |
| February 19, 2010 | Interim CAO, Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $2.94 | 25,000 | |
| February 19, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | $2.94 | 107,009 | |
| January 19, 2010 | Chief Executive Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 16,667 | -- | 114,329 | |
| January 19, 2010 | Chief Executive Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 16,667 | -- | 673,333 | |
| December 22, 2009 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,000 | $3.00 | 162,562 | |
| November 19, 2009 | Director, President & CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 6,000 | $3.21 | 71,917 | |
| August 17, 2009 | Director, President & CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.30 | 65,917 | |
| August 10, 2009 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 15,000 | $3.71 | 152,562 | |
| May 13, 2009 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 15,000 | $3.90 | 137,562 | |
| March 17, 2009 | Chief Financial Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $2.40 | 35,000 | |
| March 17, 2009 | Director, President & CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,750 | $2.56 | 60,917 | |
| January 19, 2009 | VP & Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | $2.72 | 19,000 | |
| January 19, 2009 | VP & Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,667 | $2.72 | 121,667 | |
| January 19, 2009 | VP & Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,667 | $2.72 | 133,334 | |
| January 19, 2009 | VP & Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,666 | $2.72 | 145,000 | |
| January 19, 2009 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,334 | $2.72 | 63,334 | |
| January 19, 2009 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,333 | $2.72 | 71,667 | |
| January 19, 2009 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,333 | $2.72 | 80,000 | |
| January 19, 2009 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,667 | $2.72 | 111,579 | |
| January 19, 2009 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,667 | $2.72 | 123,246 | |
| January 19, 2009 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,666 | $2.72 | 134,912 | |
| January 19, 2009 | Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,667 | $2.72 | 106,667 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
